	Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer. Prostate Scheipner L, Baudo A, Jannello LMI, Siech C, Angelis M, Bello FD, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Carmignani L, Cobelli O, Longo N, Mischinger J, Ahyai S, Karakiewicz PI. PMID: 42542968 [PubMed - as supplied by publisher]
	Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era. Prostate McMaster T, Louey CYM, Santucci J, Hobson C, Chen DD, Sathianathen N, Ischia J, Bolton DM, Lawrentschuck N, Murphy DG, Siva S, Perera M. PMID: 42542964 [PubMed - as supplied by publisher]
	Predictive Value of [-2]proPSA-Related Indices for Prostate Cancer Detection Years Before Prostate-Specific Antigen Elevation: Insights From a Five-Year Longitudinal Screening Cohort. Prostate Sekine Y, Fujizuka Y, Nakazawa S, Tsuji Y, Ohtsu A, Miyazawa Y, Arai S, Nomura M, Koike H, Matsui H, Ito K, Suzuki K. PMID: 42542963 [PubMed - as supplied by publisher]
	En-bloc Resection of Bladder Tumor Versus Conventional Transurethral Resection of Bladder Tumor: Long-term Oncological Outcomes from a Single-center Prospective Trial. Eur Urol Focus Di Bello F, Diana P, Gallioli A, Territo A, Rodriguez-Faba Ó, Gaya JM, Huguet J, Belarmino AR, Lopez M, Avesani G, Graps G, Algaba F, Palou J, Breda A. PMID: 42542426 [PubMed - as supplied by publisher]
	Tissue Memory Score captures proximal tubular identity loss and independently stratifies survival in clear cell renal cell carcinoma. Urol Oncol Khalil S, Hamdan M. PMID: 42542400 [PubMed - as supplied by publisher]
	Comment on "Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial". World J Urol Yusuf SM, Sattar A, Sharabu R. PMID: 42541579 [PubMed - in process]
	Reirradiation of locally recurrent prostate Cancer: a review of prospective evidence and delineation and planning strategies from the reirradiation Collaborative group (ReCOG). Clin Transl Radiat Oncol Slevin F, Warkentin B, Hansen J, Henry AM, Murray LJ, Murrell DH, Ong WL, Pasquier D. PMID: 42540621 [PubMed]
	Diagnosis of metastatic prostate cancer by supraclavicular lymph node excision in a patient with persistent macroscopic hematuria: A case report. Urol Case Rep Drozda V, Cierna Z, Harmanos M, Cvik M. PMID: 42540607 [PubMed]
	Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and InÂ Vitro Verification. Cancer Med Sakai T, Kawasaki Y, Sakamoto I, Hishinuma E, Matsukawa N, Chiba D, Sato T, Morozumi K, Maekawa M, Mano N, Ito A. PMID: 42538613 [PubMed - indexed for MEDLINE]
	Performance of Urine Tumor DNA Detection in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection. Eur Urol Focus Ogunkeye J, Shkolyar E, Mach KE, Prendiville S, Prado K, Shah JB, Skinner EC, Fischer DS, Phillips KG, Bicocca VT, Levin TG, Liao JC. PMID: 42538173 [PubMed - as supplied by publisher]
	Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance. Cancer Treat Res Commun Bogale DE. PMID: 42537446 [PubMed - as supplied by publisher]
	Venous thromboembolism in urothelial bladder cancer - scope of the problem and patients' perspectives: VTE-UBC. Wiad Lek Abdullah OR, Short K, Alomari LHF, Ignatowicz A, Young A. PMID: 42536929 [PubMed - indexed for MEDLINE]
	Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City. Oncology (Williston Park) Rodríguez-Olivares JL, Mauricio Mora Pineda Md, Beas-Lozano E, Alec Seidman-Sorsby Md, Remolina-Bonilla YA, Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, Bourlon MT. PMID: 42536596 [PubMed - indexed for MEDLINE]
	An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study. Medicine (Baltimore) Wei M, Pan B, Yang W, Xu W, Dong J. PMID: 42536557 [PubMed - indexed for MEDLINE]
	Risk of bladder cancer among male participants reporting nocturia in the Cancer Prevention Study-II. Cancer Epidemiol Biomarkers Prev Zhong C, Masters M, Donzella SM, Bliwise DL, Parsons H, Rees-Punia E. PMID: 42536351 [PubMed - as supplied by publisher]
	Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy. Cureus Bivolarski I, Dimitrov M, Dechev H. PMID: 42535191 [PubMed]
	Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management. Front Oncol Bakshi G, Lyon A, Joshi A, Agarwala V, Raghunath SK, Addla SK, Taneja R, Mandani A, Kashyapi B, Bhargava S, Sharma R, Agrawal V, Nagar R, Srivathsan R, Patel K, Patel R, Shah H, Lai A, Mukherjee A, Pandey S, Rajput A. PMID: 42534891 [PubMed]
	AI-driven precision diagnosis and treatment of prostate cancer: a narrative review. Front Oncol Chu T, Zhang Y, Du J, Mierxiati A. PMID: 42534734 [PubMed]
	Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review). Mol Clin Oncol N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S. PMID: 42534213 [PubMed]
	[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer. Int J Urol Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N. PMID: 42533777 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180447

Page 1 of 9023



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy